Clinical trials
Terminated Phase 2 Carcinoma, Intraductal, Noninfiltrating trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2006 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 1 |
| Georgetown University | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Mayo Clinic | 1 |
| Montefiore Medical Center | 1 |
| Roswell Park Cancer Institute | 1 |
| University of Chicago | 1 |
| University of Michigan Rogel Cancer Center | 1 |
| Vanderbilt-Ingram Cancer Center | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Intraductal, Noninfiltrating | 10 |
| Breast Carcinoma In Situ | 6 |
| Breast Neoplasms | 6 |
| Carcinoma, Lobular | 1 |
| Fibrocystic Breast Disease | 1 |
| Hot Flashes | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.